R G Vile
- Biomaterials top 2%
- Molecular Biology
- Biomedical Engineering top 10%
- Oncology top 10%
- Immunology
- Co-authors
- Kevin J. HarringtonJ.S.W. StewartA. M. PetersPaul S. UsterS. MohammadtaghiDaphne M. GlassJ WhittakerH. Chong
- Topics
- Virus-based gene therapy research (8 papers)Immunotherapy and Immune Responses (5 papers)CAR-T cell therapy research (4 papers)
- Cited by
- BiomaterialsOncologyImmunology
- Partner nations
- United KingdomUnited StatesDenmark
In The Last Decade
R G Vile
18 papers receiving 989 citations
Peers
Comparison fields: 5 of 77
- Biomaterials 490
- Molecular Biology 385
- Biomedical Engineering 338
- Oncology 250
- Immunology 190
Countries citing papers authored by R G Vile
This map shows the geographic impact of R G Vile's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R G Vile with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R G Vile more than expected).
Fields of papers citing papers by R G Vile
This network shows the impact of papers produced by R G Vile. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R G Vile. The network helps show where R G Vile may publish in the future.
Co-authorship network of co-authors of R G Vile
This figure shows the co-authorship network connecting the top 25 collaborators of R G Vile. A scholar is included among the top collaborators of R G Vile based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R G Vile. R G Vile is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 14 | |
| 2 | 7 | |
| 3 | 63 | |
| 4 | 3 | |
| 5 | 11 | |
| 6 | 149 | |
| 7 | 49 | |
| 8 | Effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled pegylated liposomes. | 461 |
| 9 | Pegylated liposome-encapsulated doxorubicin and cisplatin enhance the effect of radiotherapy in a tumor xenograft model. | 70 |
| 10 | 15 | |
| 11 | Adoptive transfer of immature dendritic cells with autologous or allogeneic tumor cells generates systemic antitumor immunity. | 42 |
| 12 | 15 | |
| 13 | 12 | |
| 14 | 54 | |
| 15 | 13 | |
| 16 | 4 | |
| 17 | 21 | |
| 18 | 5 |
About R G Vile
R G Vile is a scholar working on Otorhinolaryngology, Genetics and Immunology, having authored 18 papers that have together received 1.0k indexed citations. Recurring topics across this work include Virus-based gene therapy research (8 papers), Immunotherapy and Immune Responses (5 papers) and CAR-T cell therapy research (4 papers). The work is most often cited by research in Biomaterials (490 citations), Oncology (250 citations) and Immunology (190 citations). R G Vile has collaborated with scholars based in United Kingdom, United States and Denmark. Frequent co-authors include Kevin J. Harrington, J.S.W. Stewart, A. M. Peters, Paul S. Uster, S. Mohammadtaghi, Daphne M. Glass, J Whittaker, H. Chong, Stephen Todryk and Alan Melcher. Their work appears in journals such as British Journal of Cancer, Annals of Oncology and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.